Long-term control of extensive refractory chronic graft versus host disease in a multiple myeloma relapsing after allogeneic transplant. A case report

Federica Cocito,Silvia Mangiacavalli,Paolo Bernasconi,A. Colombo,Daniela Caldera,Claudio Salvatore Cartia,Maya Ganzetti,Daniela Troletti,Mario Cazzola,Alessandro Corso

Long-term control of extensive refractory chronic graft versus host disease in a multiple myeloma relapsing after allogeneic transplant. A case report

2017

Federica Cocito
Silvia Mangiacavalli
Paolo Bernasconi
A. Colombo
Daniela Caldera
Claudio Salvatore Cartia
Maya Ganzetti
Daniela Troletti
Mario Cazzola
Alessandro Corso

Multiple myeloma (MM) is an incurable hematological malignancy. Allogeneic stem cell transplantation (ASCT) represents a possible curative option for a subset of young and fit patients having a HLA...

Keywords:

Immunology
Graft-versus-host disease
Multiple myeloma
Medicine
Diabetes mellitus
long term control
Refractory
Oncology
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations